CN101254093B - 透皮率测定方法及皮肤电导率检测仪 - Google Patents
透皮率测定方法及皮肤电导率检测仪 Download PDFInfo
- Publication number
- CN101254093B CN101254093B CN2008100816194A CN200810081619A CN101254093B CN 101254093 B CN101254093 B CN 101254093B CN 2008100816194 A CN2008100816194 A CN 2008100816194A CN 200810081619 A CN200810081619 A CN 200810081619A CN 101254093 B CN101254093 B CN 101254093B
- Authority
- CN
- China
- Prior art keywords
- glucose
- skin
- concentration
- extraction location
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract description 28
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 393
- 239000008103 glucose Substances 0.000 claims description 393
- 238000000605 extraction Methods 0.000 claims description 317
- 239000012530 fluid Substances 0.000 claims description 103
- 239000000203 mixture Substances 0.000 claims description 93
- 238000004364 calculation method Methods 0.000 claims description 11
- 230000002195 synergetic effect Effects 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 263
- 238000004458 analytical method Methods 0.000 description 110
- 210000001519 tissue Anatomy 0.000 description 101
- 238000005259 measurement Methods 0.000 description 63
- 239000008280 blood Substances 0.000 description 51
- 210000004369 blood Anatomy 0.000 description 51
- 239000000284 extract Substances 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 42
- 239000011540 sensing material Substances 0.000 description 37
- 230000000052 comparative effect Effects 0.000 description 22
- 230000035699 permeability Effects 0.000 description 20
- 150000002500 ions Chemical class 0.000 description 19
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 14
- 229910001415 sodium ion Inorganic materials 0.000 description 14
- 239000011734 sodium Substances 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000000049 pigment Substances 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- 210000003722 extracellular fluid Anatomy 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 238000010586 diagram Methods 0.000 description 10
- 230000008520 organization Effects 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 9
- 238000004321 preservation Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 238000002203 pretreatment Methods 0.000 description 7
- 108010015776 Glucose oxidase Proteins 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000019420 glucose oxidase Nutrition 0.000 description 6
- 230000000873 masking effect Effects 0.000 description 6
- 102000013415 peroxidase activity proteins Human genes 0.000 description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000004366 Glucose oxidase Substances 0.000 description 5
- 229910021607 Silver chloride Inorganic materials 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 229940116332 glucose oxidase Drugs 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 150000002303 glucose derivatives Chemical class 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- -1 2-hydroxyl-3-sulfopropyl Chemical group 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 238000009933 burial Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940068811 digitalis preparation Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229940041492 toprol Drugs 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Images
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007048262 | 2007-02-28 | ||
| JP2007048262A JP2008206875A (ja) | 2007-02-28 | 2007-02-28 | 皮膚コンダクタンス測定装置、成分濃度分析装置、皮膚コンダクタンス測定方法および成分濃度分析方法 |
| JP2007-048262 | 2007-02-28 | ||
| JP2007078375A JP4987527B2 (ja) | 2007-03-26 | 2007-03-26 | 皮膚透過率測定方法、成分濃度分析方法、皮膚透過率測定装置および成分濃度分析装置 |
| JP2007-078375 | 2007-03-26 | ||
| JP2007078375 | 2007-03-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101254093A CN101254093A (zh) | 2008-09-03 |
| CN101254093B true CN101254093B (zh) | 2011-11-23 |
Family
ID=39783686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100816194A Expired - Fee Related CN101254093B (zh) | 2007-02-28 | 2008-02-27 | 透皮率测定方法及皮肤电导率检测仪 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2008206875A (enExample) |
| CN (1) | CN101254093B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5470010B2 (ja) * | 2008-12-22 | 2014-04-16 | シスメックス株式会社 | 生体内成分測定方法および生体内成分測定装置 |
| CN105877694A (zh) * | 2014-08-30 | 2016-08-24 | 孙宗正 | 组织液组分传感器 |
| CN104224120B (zh) * | 2014-09-15 | 2017-02-01 | 北京智谷技术服务有限公司 | 肢体内外侧识别方法和设备 |
| JP6555715B2 (ja) * | 2015-08-03 | 2019-08-07 | 国立大学法人千葉大学 | リンパ浮腫モニタ装置 |
| CN105158213B (zh) * | 2015-09-11 | 2018-08-17 | 暨南大学 | 基于光纤表面等离子体共振的葡萄糖检测装置及方法 |
| CN107361768A (zh) * | 2017-06-27 | 2017-11-21 | 深圳市宏电技术股份有限公司 | 一种检测皮肤衰老程度的方法和装置 |
| CN112354080B (zh) * | 2020-09-30 | 2024-04-19 | 未来穿戴技术有限公司 | 离子导入进度的监控方法、装置、离子导入仪及存储介质 |
| GB2604110B (en) * | 2021-02-22 | 2023-03-01 | Zelemiq Ltd | Methods and apparatus for transdermal measurement of impedance |
| CN114931378B (zh) * | 2022-04-28 | 2025-11-21 | 中国科学院大学 | 一种无创血糖检测方法 |
| CN119880888A (zh) * | 2025-03-25 | 2025-04-25 | 军事科学院系统工程研究院军需工程技术研究所 | 一种组织液葡萄糖比色检测装置及方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4817692B2 (ja) * | 2004-08-04 | 2011-11-16 | シスメックス株式会社 | 分析装置 |
-
2007
- 2007-02-28 JP JP2007048262A patent/JP2008206875A/ja not_active Withdrawn
-
2008
- 2008-02-27 CN CN2008100816194A patent/CN101254093B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101254093A (zh) | 2008-09-03 |
| JP2008206875A (ja) | 2008-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254093B (zh) | 透皮率测定方法及皮肤电导率检测仪 | |
| Pirovano et al. | A wearable sensor for the detection of sodium and potassium in human sweat during exercise | |
| JP4817692B2 (ja) | 分析装置 | |
| CA2407249C (en) | Determination of sample volume adequacy in biosensor devices | |
| US9700245B2 (en) | Transdermal analyte extraction and detection system and the method thereof | |
| US6180416B1 (en) | Method and device for predicting physiological values | |
| US6023639A (en) | Non-invasive bodily fluid withdrawal and monitoring system | |
| DE69519023T2 (de) | Einrichtung zur iontophoretischen probennahme | |
| US20050096520A1 (en) | Extracting device, extracting method, analyzer and analyzing method | |
| Peng et al. | A new oil/membrane approach for integrated sweat sampling and sensing: sample volumes reduced from μL's to nL's and reduction of analyte contamination from skin | |
| Leboulanger et al. | Lithium monitoring by reverse iontophoresis in vivo | |
| JP2006167428A (ja) | 分析物抽出装置、分析装置、分析物抽出方法および分析方法 | |
| CA2402139A1 (en) | Measurement of substances in liquids | |
| Heikenfeld | Let them see you sweat | |
| US20070232875A1 (en) | Analyzer and analyzing method | |
| US11680924B2 (en) | Method and device for determining an information on an equivalent series resistance | |
| KR20190085478A (ko) | 하나 이상의 피분석물을 샘플링하는 장치 | |
| EP1964512A2 (en) | Method of measuring skin conductance, method of analyzing component concentration, skin conductive measuring apparatus, and component concentration analyzer | |
| Yan et al. | Evaluation of constant current alternating current iontophoresis for transdermal drug delivery | |
| CN1636505B (zh) | 提取器具、提取装置和血糖值测量装置 | |
| Li et al. | In vitro and in vivo comparisons of constant resistance AC iontophoresis and DC iontophoresis | |
| RU2621153C2 (ru) | Системы и способы различия между контрольным образцом и тестируемой текучей средой с использованием емкостного сопротивления | |
| JP4987527B2 (ja) | 皮膚透過率測定方法、成分濃度分析方法、皮膚透過率測定装置および成分濃度分析装置 | |
| JP2005218855A (ja) | 経皮的分析物抽出キット、経皮的分析物抽出装置、血糖値測定装置、経皮的分析物抽出方法及び血糖値測定方法 | |
| Numajiri et al. | Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111123 Termination date: 20130227 |